The invention relates to polymorphic Forms B, C, and D of methyl(+)-(S)-α-(2-chlorophenyl)-6,7-dihydrothieno[3,2-C]pyridine-5(4H) acetate hydrobromide, to pharmaceutical compositions containing the same, and to the method of use thereof for inhibiting platelet aggregation.
该发明涉及甲基(+)-(S)-α-(2-
氯苯基)-6,7-二氢
噻吩[3,2-C]
吡啶-5(4H)
醋酸盐溴化氢的多态形式B、C和D,以及含有这些多态形式的药物组合物,以及用于抑制血小板聚集的使用方法。